MIT, Mass General team up on health IT
"MIT and MGH have uniquely synergistic and complementary strengths," said Arup Chakraborty, the Robert T. Haslam professor of chemical engineering, chemistry and biological engineering at MIT, in a press statement.
[See also: MIT center to develop new health technologies]
"Developing the cost-effective diagnostic tools, therapies and vaccines needed to overcome some of the daunting challenges facing human health today can be achieved by bringing approaches from engineering and basic science together with clinical medicine and that a strategic partnership between our institutions could achieve much more toward advancing human health," added Chakraborty, who is also the director of the MIT Institute for Medical Engineering and Science.
- Michael Cima of MIT and Herbert Lin of MGH: Development of a portable, noninvasive device capable of accurately measuring blood volume using nuclear magnetic resonance.
- Anande Dighe from MGH and Peter Szolovitz of MIT: Use of machine learning to analyze changes in a patient's lab test results over time to facilitate early diagnosis or predict the development of clinical problems.
- Matt Bianchi from MGH and Dina Katabi of MIT: Clinical trial of device using wireless signals to monitor breathing without touching a patient's body for improved diagnosis of sleep apnea.
- MIT's Brian Anthony and MGH's Anthony Samir: Adaptation of an optical system for localizing the position of ultrasound transducers, which compensates for individual operator differences, to the noninvasive monitoring of tissue loss in chronic kidney disease.
- Sangeeta Bhatia of MIT and Raymond Chung, MGH: Evaluation of liver-targeting nanosensors for the noninvasive monitoring of liver damage caused by nonalcoholic fatty liver disease and other disorders.
- Michael Filbin from MGH and Thomas Heldt of MIT: Building an archive of data collected from bedside monitoring and the electronic medical record to develop algorithms predicting the transition from sepsis to septic shock.